Pre-treatment with potent P2Y12 receptor inhibitors is associated with reduced in-hospital mortality in a real world setting of primary percutaneous coronary intervention
Event:
ESC Congress 2016
Topic:
Thrombosis and platelets
Session:
Clinical platelet studies
